content

Moderna CEO Says COVID-19 Vaccine Could Get Emergency Approval in December

As the top three COVID-19 vaccine projects get closer to the finish line, everybody is paying attention to when they might be available. Moderna...

Brazil COVID-19 vaccine trial continues despite volunteer death

Clinical trials of the Covid-19 vaccine being developed by Oxford University and AstraZeneca PLC will continue in Brazil despite the death a volunteer, Brazilian...

BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research

BioIVT, a leading provider of research models and services for drug and diagnostic development, launched its HEPATOMUNEยฎ kit, a long-term, stable, in vitro model...

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

Samsung Biologics (207940.KS) has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its...

Valicare GmbH extends GxP expertise

Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs....

GSK presents positive clinical data on maternal and older adults RSV candidate vaccines

GSK announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in...

AstraZeneca’s Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD

AstraZenecaโ€™s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read